These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37579388)

  • 21. Replenishing $13bn Global Fund is "not a given".
    Cousins S
    BMJ; 2016 Jul; 354():i4102. PubMed ID: 27448626
    [No Abstract]   [Full Text] [Related]  

  • 22. Replenishing the Global Fund to Fight AIDS, Tuberculosis, and Malaria.
    Vassall A; Masiye F
    BMJ; 2022 Sep; 378():o2320. PubMed ID: 36180075
    [No Abstract]   [Full Text] [Related]  

  • 23. The Global Fund: why anti-corruption, transparency and accountability matter.
    Chang Z; Rusu V; Kohler JC
    Global Health; 2021 Sep; 17(1):108. PubMed ID: 34537059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance.
    Clinton C; Sridhar D
    Lancet; 2017 Jul; 390(10091):324-332. PubMed ID: 28139255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Financing of global health: tracking development assistance for health from 1990 to 2007.
    Ravishankar N; Gubbins P; Cooley RJ; Leach-Kemon K; Michaud CM; Jamison DT; Murray CJ
    Lancet; 2009 Jun; 373(9681):2113-24. PubMed ID: 19541038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development assistance, donor-recipient dynamic, and domestic policy: a case study of two health interventions supported by World Bank-UK and Global Fund in China.
    Huang A; Zhao Y; Cao C; Lyu M; Tang K
    Glob Health Res Policy; 2024 Feb; 9(1):7. PubMed ID: 38310321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. It's politics, stupid! A political analysis of the HIV/AIDS Trust Fund in Uganda.
    Birungi C; Colbourn T
    Afr J AIDS Res; 2019 Dec; 18(4):370-381. PubMed ID: 31779573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming governance or reinforcing hierarchies and competition: examining the public and hidden transcripts of the Global Fund and HIV in India.
    Kapilashrami A; McPake B
    Health Policy Plan; 2013 Sep; 28(6):626-35. PubMed ID: 23144229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health technology assessments as a mechanism for increased value for money: recommendations to the Global Fund.
    Teerawattananon Y; McQueston K; Glassman A; Yothasamut J; Myint CY
    Global Health; 2013 Aug; 9():35. PubMed ID: 23965222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why is it so difficult for the Global Fund to show value for money?
    Soeters R
    Lancet Glob Health; 2013 Sep; 1(3):e123-4. PubMed ID: 25104252
    [No Abstract]   [Full Text] [Related]  

  • 31. Stakeholders' opinions and expectations of the Global Fund and their potential economic implications.
    Galárraga O; Bertozzi SM
    AIDS; 2008 Jul; 22 Suppl 1(Suppl 1):S7-S15. PubMed ID: 18664957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reaching vulnerable populations: lessons from the Global Fund to Fight AIDS, Tuberculosis and Malaria.
    Greenall M; Kunii O; Thomson K; Bangert R; Nathan O
    Bull World Health Organ; 2017 Feb; 95(2):159-161. PubMed ID: 28250520
    [No Abstract]   [Full Text] [Related]  

  • 33. Global Fund investments in human resources for health: innovation and missed opportunities for health systems strengthening.
    Bowser D; Sparkes SP; Mitchell A; Bossert TJ; Bärnighausen T; Gedik G; Atun R
    Health Policy Plan; 2014 Dec; 29(8):986-97. PubMed ID: 24197405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scaling up towards international targets for AIDS, tuberculosis, and malaria: contribution of global fund-supported programs in 2011-2015.
    Katz I; Komatsu R; Low-Beer D; Atun R
    PLoS One; 2011 Feb; 6(2):e17166. PubMed ID: 21383839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controversy embroils selection of new Global Fund head.
    Zarocostas J
    Lancet; 2017 Mar; 389(10072):e3. PubMed ID: 28258756
    [No Abstract]   [Full Text] [Related]  

  • 36. A concept in flux: questioning accountability in the context of global health cooperation.
    Bruen C; Brugha R; Kageni A; Wafula F
    Global Health; 2014 Dec; 10():73. PubMed ID: 25487705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Open letter to The Global Fund about its decision to end DPRK grants.
    Park KB; Khan U; Seung K
    Lancet; 2018 Mar; 391(10127):1257. PubMed ID: 29550024
    [No Abstract]   [Full Text] [Related]  

  • 38. The Global Fund: getting the reforms right.
    Feachem RG
    Lancet; 2011 Nov; 378(9805):1764-5. PubMed ID: 22098844
    [No Abstract]   [Full Text] [Related]  

  • 39. Fuelling the Global Fund.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2019 Feb; 19(2):113. PubMed ID: 30722994
    [No Abstract]   [Full Text] [Related]  

  • 40. The impact of Global Health Initiatives at national and sub-national level - a policy analysis of their role in implementation processes of antiretroviral treatment (ART) roll-out in Zambia and South Africa.
    Hanefeld J
    AIDS Care; 2010; 22 Suppl 1():93-102. PubMed ID: 20680864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.